CD4 and glioblastoma: CXCR6, an established marker of CD69+CD103+ Trm cells, was expressed on CD4+ Trm cells as anticipated, but also enriched in all other CD4+ T-cell subsets in glioblastoma compared to blood (Figure 3H).